Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)
Evidence to Action: Official Journal of MDCalc · 2025
DOI: 10.65357/001c.154184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence to Action: Official Journal of MDCalc, 2025. Verfasst von Jayachidambaram Ambalavanan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
HOMA-IR is used to estimate prevalence of insulin resistance in individuals who are at risk of developing metabolic syndrome and diabetes. This review summarizes pearls, pitfalls and practical application of the calculator.
Zitieren
APA
Ambalavanan, J. (2025). Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance). Evidence to Action: Official Journal of MDCalc. https://doi.org/10.65357/001c.154184
Vancouver
Ambalavanan J. Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance). Evidence to Action: Official Journal of MDCalc. 2025. doi:10.65357/001c.154184
BibTeX
@article{Ambalavanan2025,
author = {Ambalavanan, Jayachidambaram},
title = {Updated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)},
journal = {Evidence to Action: Official Journal of MDCalc},
year = {2025},
doi = {10.65357/001c.154184}
}
EUVIMED